摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

雄甾-5-烯-7,17-二酮 | 567-74-8

中文名称
雄甾-5-烯-7,17-二酮
中文别名
——
英文名称
androst-5-ene-7,17-dione
英文别名
androst-5-en-7,17-dione;5-androstene-7,17-dione;(8R,9S,10R,13S,14S)-10,13-dimethyl-2,3,4,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-7,17-dione
雄甾-5-烯-7,17-二酮化学式
CAS
567-74-8
化学式
C19H26O2
mdl
——
分子量
286.414
InChiKey
SVDSXMKJDCDWLU-ZENYQMPMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    21
  • 可旋转键数:
    0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.79
  • 拓扑面积:
    34.1
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    雄甾-5-烯-7,17-二酮potassium permanganatesodium periodatepotassium carbonate 作用下, 以 叔丁醇 为溶剂, 反应 1.5h, 以2.45 g的产率得到5,17-dioxo-5,7-seco-6-norandrostan-7-oic acid
    参考文献:
    名称:
    Hanson, James R.; Uyanik, Cavit, Journal of Chemical Research, Miniprint, 1998, # 5, p. 1032 - 1042
    摘要:
    DOI:
  • 作为产物:
    描述:
    5-androsten-17-one 在 mercury(II) trifluoroacetate 、 碳酸氢钠 作用下, 生成 雄烯二酮3β,6β-dihydroxyandrost-4-en-17-one雄甾-5-烯-7,17-二酮
    参考文献:
    名称:
    δ5-类固醇与三氟乙酸汞(II)反应的范围和局限性
    摘要:
    摘要 研究了C-3 取代基对雄性5-烯与三氟乙酸汞(II) 在二氯甲烷中反应(改性Treibs 氧化)的影响。3β-Acyloxyandrost-5-en-17-ones 得到 3β-acyloxy-6β-hydroxyandrost-4-en-17-ones 伴随着 3β-acyloxy-6-chloromercuriandrost-5-en-17-ones。3β-Acetoxy-6β-trifluoroacetoxyandrost-4-en-17-one 和 3β-acetoxy-4β-trifluoroacetoxyandrost-5-en-17-one 是反应的中间体。氯汞类固醇的形成表明溶剂参与了反应。以 3α-acetoxyandrost-5-en-17-one 作为底物,观察到产物分布的完全逆转。3β-Haloandrost-5-en-17-ones 的主要产物反映了卤化物的
    DOI:
    10.1016/s0039-128x(98)00076-2
点击查看最新优质反应信息

文献信息

  • Microwave induced selective enolization of steroidal ketones and efficient acetylation of sterols in semisolid state
    作者:Padma Marwah、Ashok Marwah、Henry A. Lardy
    DOI:10.1016/s0040-4020(03)00207-2
    日期:2003.3
    Under microwave irradiation steroidal enones, more specifically, position three carbonyls were efficiently and selectively converted to the corresponding enol acetates in the presence of additional enolizable carbonyl functions at other positions, using acetic anhydride and a catalytic amount of toluene-p-sulfonic acid. Acetylation of hydroxyl groups of the sterols, including those at the hindered
    在微波辐射下,更具体地,使用乙酸酐和催化量的甲苯-对磺酸,在其他位置存在另外的可烯丙基的羰基官能团的情况下,在其他位置上,将三个位置的羰基化合物有效且选择性地转化为相应的烯醇乙酸酯。固醇的羟基的乙酰化,包括在受阻位置的羟基,几乎是定量的。严格的无水条件不是乙酰化的前提条件,反应系统很容易耐受高达10%(v / v)的水分。
  • Process for preparing 6-methylene steroids
    申请人:Schering Aktiengesellschaft
    公开号:US04322349A1
    公开(公告)日:1982-03-30
    A process for preparing a 6-methylene-.DELTA..sup.4 -3-keto steroid of the formula ##STR1## wherein R is hydrogen, alkoxy of up to 6 carbon atoms or acyloxy of up to 6 carbon atoms wherein the acyl group is that of a carboxylic acid, and R' is the CD-ring system of a steroid of the androstane or pregnane series, comprising reacting the corresponding .DELTA..sup.4 -3-keto steroid of the formula ##STR2## with a formaldehyde derivative of the formula X(CH.sub.2 O).sub.n Y wherein n is 1, 3 or an integer on the order of 100-1000, and X is C.sub.1-5 alkoxy and Y is C.sub.1-5 alkyl when n is 1, X and Y represent a single bond between the terminal C atom and the terminal O atom when n is 3, and X is hydroxy and Y is hydrogen when n is an integer on the order of 100-1000, in an inert solvent in the presence of a condensation agent which is a strong acid a strongly acidic cation exchanger or a phosphoric acid derivative.
    一种制备式的6-亚甲基-Δ4-3-酮类固醇的方法,其中R为氢、最多含有6个碳原子的烷氧基或最多含有6个碳原子的乙酰氧基,其中酰基是羧酸的酰基,R'为雄甾烷或孕烷系列类固醇的CD环系统,包括将相应的Δ4-3-酮类固醇与式的甲醛衍生物反应X(CH2O)nY,其中n为1、3或约为100-1000的整数,X为C1-5烷氧基,Y为C1-5烷基,当n为1时,X和Y代表末端C原子和末端O原子之间的单键,当n为3时,X和Y代表末端C原子和末端O原子之间的单键,当n为约为100-1000的整数时,X为羟基,Y为氢,在惰性溶剂中,在存在强酸、强酸性阳离子交换剂或磷酸衍生物的缩聚剂的情况下进行。
  • [EN] METHODS FOR PREPARING 17-ALKYNYL-7-HYDROXY STEROIDS AND RELATED COMPOUNDS<br/>[FR] PROCÉDÉS DE PRÉPARATION DE COMPOSÉS 17-ALKYNYL-7-HYDROXY STÉROÏDES ET COMPOSÉS ASSOCIÉS
    申请人:HOLLIS EDEN PHARMACEUTICALS
    公开号:WO2009149392A1
    公开(公告)日:2009-12-10
    The invention relates to processes for preparing 17-alkynyl-7-hydroxy- steroids, such as 17-Ethynyl-10R13S-dimethyl 2,3,4,7,8R,9S, 10,11,12,13,14S,15,16,17-hexadecahydro-1 H-cyclopenta[a]phenanthrene- 3R,7R,17S-triol (also referred to as 17α-ethynyl-androst-5-ene-3β,7β,17β-triol), that are essentially free of process impurities having binding activity at nuclear estrogen receptors.
    该发明涉及制备17-炔基-7-羟基类固醇的过程,例如17-乙炔基-10R13S-二甲基2,3,4,7,8R,9S,10,11,12,13,14S,15,16,17-十六氢-1H-环戊[α]苯并-3R,7R,17S-三醇(也称为17α-乙炔基-雄烯-5-烯-3β,7β,17β-三醇),这些类固醇基本上不含有在核雌激素受体上具有结合活性的工艺杂质。
  • METHODS FOR PREPARING 17-ALKYNYL-7-HYDROXY STEROIDS AND RELATED COMPOUNDS
    申请人:White Steven K.
    公开号:US20090326251A1
    公开(公告)日:2009-12-31
    The invention relates to processes for preparing 17-alkynyl-7-hydroxy-steroids, such as 17-Ethynyl-10R,13S-dimethyl 2,3,4,7,8R,9S, 10,11,12,13,14S,15,16,17-hexadecahydro-1H-cyclopenta[a]phenanthrene-3R,7R,17S-triol (also referred to as 17α-ethynyl-androst-5-ene-3β,7β,17β-triol), that are essentially free of process impurities having binding activity at nuclear estrogen receptors.
    本发明涉及制备17-炔基-7-羟基类固醇的过程,例如17-乙炔基-10R,13S-二甲基2,3,4,7,8R,9S,10,11,12,13,14S,15,16,17-十六烷基-1H-环戊[a]苯并[3R,7R,17S]-三醇(也称为17α-乙炔基-雄甾-5-烯-3β,7β,17β-三醇),其基本上不含有核雌激素受体结合活性的过程杂质。
  • METHODS FOR PREPARING 17-ALKYNYL-7-HYDROXY STEROIDS AND RELATED COMPOUNDS-2
    申请人:White Steven K.
    公开号:US20130066087A1
    公开(公告)日:2013-03-14
    The invention relates to processes for preparing 17-alkynyl-7-hydroxy-steroids, such as 17-Ethynyl-10R,13S-dimethyl 2,3,4,7,8R,9S,10,11,12,13,14S,15,16,17-hexadecahydro-1H-cyclopenta[a]phenanthrene-3R,7R,17S-triol (also referred to as 17α-ethynyl-androst-5-ene-3β,7β,17β-triol), that are essentially free of process impurities having binding activity at nuclear estrogen receptors.
    本发明涉及制备17-炔基-7-羟基类固醇的过程,例如17-乙炔基-10R,13S-二甲基2,3,4,7,8R,9S,10,11,12,13,14S,15,16,17-十六烷基-1H-环戊[a]苯并[3R,7R,17S]-三醇(也称为17α-乙炔基-雄甾-5-烯-3β,7β,17β-三醇),其基本上不含有在核雌激素受体上具有结合活性的过程杂质。
查看更多